{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:23:26Z","timestamp":1789662206293,"version":"4.0.1"},"reference-count":54,"publisher":"Frontiers Media SA","issue":"12","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["Grant Nr. P3-0323"],"award-info":[{"award-number":["Grant Nr. P3-0323"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Medical Centre Ljubljana","award":["Grant Nr. 20110090"],"award-info":[{"award-number":["Grant Nr. 20110090"]}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/tri.13323","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T08:30:30Z","timestamp":1533025830000},"page":"1391-1404","source":"Crossref","is-referenced-by-count":15,"title":["Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial"],"prefix":"10.3389","volume":"31","author":[{"given":"Manca","family":"Oblak","sequence":"first","affiliation":[{"name":"Department of Nephrology; University Medical Centre Ljubljana; Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Mlin\u0161ek","sequence":"additional","affiliation":[{"name":"Department of Nephrology; University Medical Centre Ljubljana; Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljo\u0161a","family":"Kandus","sequence":"additional","affiliation":[{"name":"Department of Nephrology; University Medical Centre Ljubljana; Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadranka","family":"Buturovi\u0107-Ponikvar","sequence":"additional","affiliation":[{"name":"Department of Nephrology; University Medical Centre Ljubljana; Ljubljana Slovenia"},{"name":"Faculty of Medicine; University of Ljubljana; Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-7820","authenticated-orcid":false,"given":"Miha","family":"Arnol","sequence":"additional","affiliation":[{"name":"Department of Nephrology; University Medical Centre Ljubljana; Ljubljana Slovenia"},{"name":"Faculty of Medicine; University of Ljubljana; Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"10.1111\/tri.13323-BIB0001|tri13323-cit-0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0002|tri13323-cit-0002","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1600-6143.2012.04101.x","article-title":"Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial","volume":"12","author":"Weiner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0003|tri13323-cit-0003","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.transproceed.2013.01.102","article-title":"High mortality in the first year after kidney graft failure","volume":"45","author":"Buturovi\u0107-Ponikvar","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.13323-BIB0004|tri13323-cit-0004","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/j.1600-6143.2007.02010.x","article-title":"Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0005|tri13323-cit-0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/TP.0b013e3181c352c5","article-title":"The clinical significance of early proteinuria after renal transplantation","volume":"89","author":"Cherukuri","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.13323-BIB0006|tri13323-cit-0006","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/TP.0000000000000894","article-title":"Evaluation and management of proteinuria after kidney transplantation","volume":"99","author":"Tsampalieros","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.13323-BIB0007|tri13323-cit-0007","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/j.1600-6143.2007.02006.x","article-title":"Proteinuria after kidney transplantation, relationship to allograft histology and survival","volume":"7","author":"Amer","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0008|tri13323-cit-0008","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0009|tri13323-cit-0009","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.13323-BIB0010|tri13323-cit-0010","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1016\/j.transproceed.2011.08.081","article-title":"Impact of vitamin D on proteinuria, insulin resistance, and cardiovascular parameters in kidney transplant recipients","volume":"43","author":"Lee","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.13323-BIB0011|tri13323-cit-0011","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1681\/ASN.2012060614","article-title":"Vitamin D status and outcomes after renal transplantation","volume":"24","author":"Bienaime","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0012|tri13323-cit-0012","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"Borst","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0013|tri13323-cit-0013","doi-asserted-by":"crossref","first-page":"145828","DOI":"10.1155\/2015\/145828","article-title":"Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system","volume":"2015","author":"Santoro","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1111\/tri.13323-BIB0014|tri13323-cit-0014","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/ndt\/17.12.2132","article-title":"22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorous metabolism in subtotally nephrectomised rats","volume":"17","author":"Hirata","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13323-BIB0015|tri13323-cit-0015","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/tri.13323-BIB0016|tri13323-cit-0016","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13323-BIB0017|tri13323-cit-0017","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","article-title":"Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signalling","volume":"19","author":"Tan","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0018|tri13323-cit-0018","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","article-title":"Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial","volume":"13","author":"Amer","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0019|tri13323-cit-0019","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients","volume":"95","author":"Gonzalez","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13323-BIB0020|tri13323-cit-0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1111\/tri.13323-BIB0021|tri13323-cit-0021","first-page":"122","article-title":"Proteinuria in kidney transplant recipients: prevalence in a national cohort and study design of the effect of paricalcitol for reduction of proteinuria","volume":"24","author":"Arnol","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13323-BIB0022|tri13323-cit-0022","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2007.02.006","article-title":"A simple sample size formula for analysis of covariance in randomized clinical trials","volume":"60","author":"Borm","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/tri.13323-BIB0023|tri13323-cit-0023","doi-asserted-by":"crossref","first-page":"253","DOI":"10.20982\/tqmp.12.3.p253","article-title":"Violation of the homogeneity of regression slopes assumption in ANCOVA for two-group pre-post designs: tutorial on a modified Johnson-Neyman procedure","volume":"12","author":"Johnson","year":"2016","journal-title":"Quantitat Methods Psychol"},{"key":"10.1111\/tri.13323-BIB0024|tri13323-cit-0024","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13323-BIB0025|tri13323-cit-0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/tri.13323-BIB0026|tri13323-cit-0026","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.13323-BIB0027|tri13323-cit-0027","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2369-14-163","article-title":"Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial","volume":"14","author":"Larsen","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1111\/tri.13323-BIB0028|tri13323-cit-0028","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0029|tri13323-cit-0029","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/tri.12973","article-title":"Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study","volume":"30","author":"Pihlstr\u00f8m","year":"2017","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13323-BIB0030|tri13323-cit-0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ckj\/sfu132","article-title":"Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy","volume":"8","author":"Chen","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1111\/tri.13323-BIB0031|tri13323-cit-0031","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2369-13-150","article-title":"Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study","volume":"13","author":"Nicola","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1111\/tri.13323-BIB0032|tri13323-cit-0032","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ki.1989.190","article-title":"Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril","volume":"36","author":"Heeg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13323-BIB0033|tri13323-cit-0033","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0034|tri13323-cit-0034","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(14)70030-0","article-title":"Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial","volume":"2","author":"Kwakernaak","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1111\/tri.13323-BIB0035|tri13323-cit-0035","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1681\/ASN.2016040407","article-title":"Effects of vitamin D receptor activation and dietary sodium restriction on residual albuminuria in CKD: the ViRTUE-CKD trial","volume":"28","author":"Keyzer","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0036|tri13323-cit-0036","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/tri.13323-BIB0037|tri13323-cit-0037","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2009080872","article-title":"Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system","volume":"21","author":"Zhang","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0038|tri13323-cit-0038","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13323-BIB0039|tri13323-cit-0039","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0040|tri13323-cit-0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.2009121236","article-title":"Blockade of Wnt\/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury","volume":"22","author":"He","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0041|tri13323-cit-0041","first-page":"1293","article-title":"Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy","volume":"32","author":"Mirkovic","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13323-BIB0042|tri13323-cit-0042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MJT.0b013e3181d16999","article-title":"Role of vitamin D in blood pressure homeostasis","volume":"17","author":"Feneis","year":"2010","journal-title":"Am J Ther"},{"key":"10.1111\/tri.13323-BIB0043|tri13323-cit-0043","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","article-title":"Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data","volume":"175","author":"Beveridge","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1111\/tri.13323-BIB0044|tri13323-cit-0044","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ki.2012.311","article-title":"Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease","volume":"83","author":"Boer","year":"2013","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13323-BIB0045|tri13323-cit-0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000441364","article-title":"Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial","volume":"42","author":"Lundwall","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1111\/tri.13323-BIB0046|tri13323-cit-0046","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/eji.1830170420","article-title":"Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations","volume":"17","author":"Rigby","year":"1987","journal-title":"Eur J Immunol"},{"key":"10.1111\/tri.13323-BIB0047|tri13323-cit-0047","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11882-010-0161-8","article-title":"The impact of vitamin D on regulatory T cells","volume":"11","author":"Chambers","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/tri.13323-BIB0048|tri13323-cit-0048","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.104.078659","article-title":"Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia\/reperfusion","volume":"312","author":"Patel","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/tri.13323-BIB0049|tri13323-cit-0049","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1093\/ndt\/gfr163","article-title":"Inflammation-associated graft loss in renal transplant recipients","volume":"26","author":"Dahle","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13323-BIB0050|tri13323-cit-0050","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2010.141325","article-title":"Impact of IL-6 receptor inhibition on human memory B cells\u00a0in\u00a0vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells","volume":"70","author":"Muhammad","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/tri.13323-BIB0051|tri13323-cit-0051","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of tocilizumab (anti-interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA-sensitized renal allograft recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13323-BIB0052|tri13323-cit-0052","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.2015010062","article-title":"Proteinuria as a noninvasive marker for renal allograft histology and failure: an observational cohort study","volume":"27","author":"Naesens","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13323-BIB0053|tri13323-cit-0053","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ki.2011.207","article-title":"Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate","volume":"80","author":"Agarwal","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13323-BIB0054|tri13323-cit-0054","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01760408","article-title":"Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients","volume":"3","author":"Shinaberger","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.13323","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.13323\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:40:58Z","timestamp":1641062458000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.13323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.13323","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,20]]}}}